Target intelligence / Profile preview

Cytochrome c1, heme protein, mitochondrial (CYC1)

Target
CYC1
Molecular classification
Enzyme, Oxidoreductase, Respiratory chain protein, Mitochondrial membrane protein
01

Overview

Cytochrome c1 is a 30-kDa membrane-bound heme protein that serves as a catalytic subunit of mitochondrial complex III (cytochrome bc1 complex). It facilitates the transfer of electrons from the Rieske iron-sulfur protein to cytochrome c during oxidative phosphorylation. Cytochrome c1 is anchored in the inner mitochondrial membrane, with its functional domain projecting into the intermembrane space. Dysfunction of cytochrome c1 impairs electron flow in the respiratory chain, leading to decreased ATP production and increased reactive oxygen species. Mutations in CYC1 are linked to rare mitochondrial diseases. Cytochrome c1 arose evolutionarily from a collapse of a di-heme cytochrome c4 ancestor, and maintains a mono-heme structure essential for its role in electron transfer. It is a highly conserved protein across eukaryotes, and bears sequence homology indicating its functional and evolutionary significance in cellular respiration.

Other names
CYC1Cytochrome c1Cytochrome bc1 complex subunit 3Complex III subunit 3Mitochondrial cytochrome c1
02

Mechanism of action

Inhibitors of cytochrome bc1 complex (complex III) prevent electron transfer between ubiquinol and cytochrome c, collapsing the proton gradient and impairing ATP synthesis, leading to cell death or dysfunction

03

Biological functions

Electron transport chain (mitochondrial respiratory chain)Cellular respiration (energy production)Couples oxidation-reduction reactions for ATP synthesis
04

Disease associations

Mitochondrial disorders (mutations can cause mitochondrial complex III deficiency)Cardiovascular disease (through impact on cellular energy supply)Neurodegenerative diseases (due to impaired electron transport and ROS production)Cancer (mitochondrial dysfunction is associated with tumorigenesis)
05

Safety considerations

Non-specific inhibition of cytochrome c1 or complex III results in disruption of ATP production, leading to tissue damage—especially in CNS, heart, and muscle.Off-target mitochondrial toxicity and cell death
06

Interacting drugs

Antimycin A (complex III inhibitor)

2 more in the full profile.

07

Biomarkers

CYC1 gene or protein levels may serve as markers for mitochondrial disease diagnosis or monitoring, but are not commonly used clinically as standalone markers.Deficiency or dysfunction is detected by activity assays for complex III in diagnostic laboratories.

Beyond the preview

Go deeper on Cytochrome c1, heme protein, mitochondrial (CYC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome c1, heme protein, mitochondrial (CYC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call